160 related articles for article (PubMed ID: 23545578)
1. Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor.
Zhang N; Wu P; Shayiremu D; Wu L; Shan H; Ye L; Zhao X; Cai J; Jiang WG; Gong K; Yang Y
Int J Oncol; 2013 May; 42(5):1664-73. PubMed ID: 23545578
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth inhibitor (VEGI) in human urothelial cancer of the bladder and its effects on the adhesion and migration of bladder cancer cells in vitro.
Zhang N; Sanders AJ; Ye L; Kynaston HG; Jiang WG
Anticancer Res; 2010 Jan; 30(1):87-95. PubMed ID: 20150621
[TBL] [Abstract][Full Text] [Related]
3. A novel secreted splice variant of vascular endothelial cell growth inhibitor.
Chew LJ; Pan H; Yu J; Tian S; Huang WQ; Zhang JY; Pang S; Li LY
FASEB J; 2002 May; 16(7):742-4. PubMed ID: 11923219
[TBL] [Abstract][Full Text] [Related]
4. VEGI-192, a new isoform of TNFSF15, specifically eliminates tumor vascular endothelial cells and suppresses tumor growth.
Hou W; Medynski D; Wu S; Lin X; Li LY
Clin Cancer Res; 2005 Aug; 11(15):5595-602. PubMed ID: 16061878
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth inhibitor 174 is a negative regulator of aggressiveness and microvascular density in human clear cell renal cell carcinoma.
Wu L; Li X; Ye L; Shayiremu D; Deng X; Zhang X; Jiang W; Yang Y; Gong K; Zhang N
Anticancer Res; 2014 Feb; 34(2):715-22. PubMed ID: 24511004
[TBL] [Abstract][Full Text] [Related]
6. The differential expression of vascular endothelial growth inhibitor isoforms, VEGI251, VEGI174 and VEGI192 in human clear-cell renal cell carcinoma.
Zhang N; Wu P; Wu L; Shayiremu D; Shan H; Ye L; Jiang WG; Gong K; Yang Y
Cancer Genomics Proteomics; 2013; 10(1):47-53. PubMed ID: 23382586
[TBL] [Abstract][Full Text] [Related]
7. Protein of Vascular Endothelial Growth Inhibitor 174 Inhibits Epithelial-Mesenchymal Transition in Renal Cell Carcinoma
Zhao Q; Deng X; Hong B; Wang F; Tang X; Yang Y; Gong K; Ye L; Jiang WG; Zhang N
Anticancer Res; 2017 Aug; 37(8):4269-4275. PubMed ID: 28739718
[TBL] [Abstract][Full Text] [Related]
8. [Expression and role of vascular endothelial growth inhibitor in sporadic clear cell renal cell carcinoma].
Wu LY; Cheng H; Deng XH; Shan H; Wang W; Yang Y; Zhang XD; Zhang N
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(10):741-5. PubMed ID: 23755810
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth inhibitor, expression in human prostate cancer tissue and the impact on adhesion and migration of prostate cancer cells in vitro.
Zhang N; Sanders AJ; Ye L; Kynaston HG; Jiang WG
Int J Oncol; 2009 Dec; 35(6):1473-80. PubMed ID: 19885571
[TBL] [Abstract][Full Text] [Related]
10. VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis.
Xiao T; Fan JK; Huang HL; Gu JF; Li LY; Liu XY
Cell Res; 2010 Mar; 20(3):367-78. PubMed ID: 19918267
[TBL] [Abstract][Full Text] [Related]
11. Identification of Novel Proteins Interacting with Vascular Endothelial Growth Inhibitor 174 in Renal Cell Carcinoma.
Zhao Q; Kun D; Hong B; Deng X; Guo S; Tang X; Yang Y; Gong K; Li Q; Ye L; Jiang WG; Zhang N
Anticancer Res; 2017 Aug; 37(8):4379-4388. PubMed ID: 28739731
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesis.
Metheny-Barlow LJ; Li LY
Semin Ophthalmol; 2006; 21(1):49-58. PubMed ID: 16517446
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
[TBL] [Abstract][Full Text] [Related]
14. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells.
Kumanishi S; Yamanegi K; Nishiura H; Fujihara Y; Kobayashi K; Nakasho K; Futani H; Yoshiya S
Int J Oncol; 2019 Jul; 55(1):167-178. PubMed ID: 31180533
[TBL] [Abstract][Full Text] [Related]
16. Vascular Endothelial Growth Inhibitor, a Cytokine of the Tumor Necrosis Factor Family, is Associated With Epithelial-Mesenchymal Transition in Renal Cell Carcinoma.
Zhao Q; Liu T; Hong B; Wang F; Zhou C; Du X; Chen S; Deng X; Duoerkun S; Li Q; Yang Y; Gong K; Zhang N
Appl Immunohistochem Mol Morphol; 2018; 26(10):727-733. PubMed ID: 28362712
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth inhibitor affects the invasion, apoptosis and vascularisation in breast cancer cell line MDA-MB-231.
Gao Y; Ge Z; Zhang Z; Bai Z; Ma X; Wang Y
Chin Med J (Engl); 2014; 127(10):1947-53. PubMed ID: 24824261
[TBL] [Abstract][Full Text] [Related]
18. Expression of gastrin releasing Peptide receptor in renal cell carcinomas: a potential function for the regulation of neoangiogenesis and microvascular perfusion.
Heuser M; Schlott T; Schally AV; Kahler E; Schliephake R; Laabs SO; Hemmerlein B
J Urol; 2005 Jun; 173(6):2154-9. PubMed ID: 15879878
[TBL] [Abstract][Full Text] [Related]
19. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
[TBL] [Abstract][Full Text] [Related]
20. RNAi-mediated knockdown of vascular endothelial growth factor inhibits vascularization and tumor growth in renal cell carcinoma.
Gu M; Zhang K; Yao HJ; Zhou J; Peng YB; Xu MX; Wang Z
Int J Mol Med; 2015 Oct; 36(4):1063-72. PubMed ID: 26310563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
